Business Context and Reporting Period
This Form 6-K filing is submitted by GlaxoSmithKline plc and GlaxoSmithKline Capital plc for the month of October 2020. The registrants are foreign private issuers based in Brentford, Middlesex, United Kingdom. The report serves to incorporate legal opinions by reference into the registrants' Registration Statement on Form F-3 (File Nos. 333-223982 and 333-223982-02).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, liquidity, or other key financial metrics. This document is a procedural filing regarding legal opinions and does not contain financial performance data.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No financial or operational comparisons are included in this specific report.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to the incorporation of legal opinions from Cleary Gottlieb Steen & Hamilton LLP (Exhibits 5.1 and 5.2) into the Form F-3 registration statement.
Investor Verification Checklist
- Verify the status of the Registration Statement on Form F-3 (File Nos. 333-223982 and 333-223982-02) to understand the context of the incorporated legal opinions.
- Review the full text of Exhibits 5.1 and 5.2 (Opinions of Cleary Gottlieb Steen & Hamilton LLP) for specific legal conclusions relevant to the registrants.
- Consult the most recent Form 20-F or quarterly earnings release for actual financial performance data, as this Form 6-K contains none.